Form D · Biotechnology
PathCision Medicine, Inc.
Watertown, MA · CIK 0001959064
Offering snapshot reported Feb 5, 2026 · SEC filing
- Reported sold
- $1.7M Offering amount: $3M
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Nov 10, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 5, 2026 | Amendment | $1,700,000 | No comparison | 8 | SEC filing |
| Feb 21, 2024 | Initial | $200,000 | No comparison | 3 | SEC filing |
| Dec 30, 2022 | Initial | $600,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-505665
Source: Form D, filed Feb 5, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Yang Lee | Director, Executive |
| Hui Hsuan Wang | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
134 Coolidge Avenue #2
Watertown, MA, 02472
Watertown, MA, 02472